National Disease Research Interchange: Funding & Investors (Aug 2026)
National Disease Research Interchange is the source of human tissues, cells and organs for scientific research.
National Disease Research Interchange has raised $14.4M across 1 funding round on record, the most recent an undisclosed round of $14.4M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
National Disease Research Interchange Company Profile and Key Stats
Latest funding round on record: May 2023.
National Disease Research Interchange Funding Rounds
National Disease Research Interchange Founders and Leadership Team
Contact details for the National Disease Research Interchange team: 1 of 1 has an email address on file.
Start 14-day free trial →National Disease Research Interchange Funding Compared to Other Biotechnology Startups
National Disease Research Interchange's latest round of $14.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like National Disease Research Interchange in Biotechnology and Philadelphia
Companies Similar to National Disease Research Interchange
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
National Disease Research Interchange Funding FAQs
What does National Disease Research Interchange do?
National Disease Research Interchange is the source of human tissues, cells and organs for scientific research.
How much funding has National Disease Research Interchange raised?
National Disease Research Interchange has raised $14.4M across 1 round on record. The most recent is an undisclosed round of $14.4M announced in May 2023.
When did National Disease Research Interchange last raise funding?
National Disease Research Interchange's most recent funding round on record is an undisclosed round of $14.4M, announced in May 2023.
Who is the CEO of National Disease Research Interchange?
Bill Leinweber is listed as CEO at National Disease Research Interchange.
Where is National Disease Research Interchange headquartered?
National Disease Research Interchange is based in Philadelphia, Pennsylvania, United States.
How many employees does National Disease Research Interchange have?
National Disease Research Interchange is in the 51-100 employee band.
How does National Disease Research Interchange's funding compare to other Biotechnology startups?
National Disease Research Interchange's latest round of $14.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's National Disease Research Interchange Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for National Disease Research Interchange is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.